Howard Hughes Medical Institute CEO salary and executive pay

Howard Hughes Medical Institute paid its CEO, Erin K O'Shea PhD, $1,721,384 for the fiscal year ending August 2025. That is up $60,746 (3.7%) from the fiscal year ending August 2024. Total revenue on that return was $2,004,784,057, up 13.9% from $1,760,221,928 for the fiscal year ending August 2024. Howard Hughes Medical Institute ranks 4th of 11 disease charities and medical research groups on this site by CEO pay. Howard Hughes Medical Institute has 4 Form 990 returns on record, for fiscal years ending 2022 to 2025.

Last updated from IRS e-file data. EIN 59-0735717, Chevy Chase, MD.

CEO, fiscal year ending August 2025

$1,721,384

Erin K O'Shea PhDPRESIDENT

Highest-paid person, fiscal year ending August 2025

$2,004,966Donald KochVP & CHIEF INVESTMENT OFFICER

Total revenue
$2,004,784,057
CEO pay vs. peers
Higher than 21%

Source: Form 990, fiscal year ending August 2025, IRS object ID 202640419349301864.View the filing

Peers: the 330 other organizations on this site with revenue of $500 million to $5 billion. Ranked 259th of 331 by top pay as a share of revenue. Pay is 0.09% of revenue, our calculation from the same return. Revenue is Part I, line 12; peers are compared on their latest full-year returns.

Highest-paid people on the latest return

On the latest return, 18 people were paid more than $500,000, 5 of them more than $1 million.

Name and titleTotal
Donald KochVP & CHIEF INVESTMENT OFFICER$2,004,966
Erin K O'Shea PhD
CEO
PRESIDENT
$1,721,384
Mark SprolesMANAGING DIRECTOR, PRIVATE MARKETS$1,244,070
Karen EiflerMANAGING DIRECTOR, PUBLIC MARKETS$1,196,207
Glen ZwickerMANAGING DIRECTOR & HEAD OF INVESTMENT OPERATIONS$1,118,524
Total: Part VII columns D, E and F added together.

Also paid on the latest return: Heidi E Henning Esq (VP & GENERAL COUNSEL & SECRETARY), $887,510; Richard Axel MD (INVESTIGATOR), $854,925; Leslie B Vosshall PhD (VP & CHIEF SCIENTIFIC OFFICER), $850,327; Blanton Tolbert PhD (VP SCIENCE LEADERSHIP AND CULTURE (THRU 05/25)/LAB HEAD), $833,368; Ronald Vale PhD (SENIOR GROUP LEADER/FORMER VP & EXEC. DIR., JRC), $826,070; Nelson Spruston PhD (VP & EXEC DIR, JANELIA RESEARCH CAMPUS), $715,383; David E Clapham PhD (SENIOR GROUP LEADER/FORMER VP & CHIEF SCIENTIFIC OFFICER), $663,738; Gerald M Rubin PhD (SENIOR GROUP LEADER/FORMER VP & EXEC. DIR., JRC), $661,837; Sean B Carroll PhD (INVESTIGATOR/FORMER VP SCI. & ED. MEDIA GROUP), $655,265; Seth Grossman Esq (VP, CHIEF OPERATING OFFICER & SENIOR ADVISOR TO THE PRESIDENT), $588,161; Lynne Lochte (CHIEF FINANCIAL OFFICER & TREASURER), $534,890; Kristina Heiberger Esq (DEPUTY GENERAL COUNSEL & ASSISTANT SECRETARY), $507,283; Bodo Stern PhD (CHIEF OF STRATEGIC INITIATIVES), $500,810; Natasha Neises (SENIOR DIRECTOR, FINANCIAL PLANNING & ANALYSIS), $339,650; Jeremy Compton (CONTROLLER), $305,482; and 14 more.

CEO pay by year

Each row is the CEO on that year's return.

Fiscal year endingName and titleTotalRevenueSource
Aug 2025Erin K O'Shea PhD
CEO
PRESIDENT
$1,721,384$2,004,784,057Filing
Aug 2024Erin K O'Shea PhD
CEO
PRESIDENT
$1,660,638$1,760,221,928Filing
Aug 2023ERIN K O'SHEA PHD
CEO
PRESIDENT
$1,639,888$749,022,788Filing
Aug 2022ERIN K O'SHEA PHD
CEO
PRESIDENT
$1,548,899$2,117,477,557Filing
Total: Part VII columns D, E and F. Revenue: Part I, line 12.

How this pay was reported

The parts of each total, as reported on the return for the fiscal year ending August 2025.

Source: Form 990, fiscal year ending August 2025, IRS object ID 202640419349301864.View the filing

Part VIISchedule J
Name and titleFrom orgOtherBaseBonusOtherDeferredNontaxableTotal
Donald KochVP & CHIEF INVESTMENT OFFICER$1,928,020$76,946$1,140,785$765,853$21,382$34,500$42,446$2,004,966
Erin K O'Shea PhDPRESIDENT$1,652,120$69,264$1,622,670$0$29,450$34,500$34,764$1,721,384
Mark SprolesMANAGING DIRECTOR, PRIVATE MARKETS$1,207,419$36,651$605,195$576,365$25,859$34,500$2,151$1,244,070
Karen EiflerMANAGING DIRECTOR, PUBLIC MARKETS$1,160,055$36,152$619,136$538,964$1,955$34,500$1,652$1,196,207
Glen ZwickerMANAGING DIRECTOR & HEAD OF INVESTMENT OPERATIONS$1,043,689$74,835$546,919$472,358$24,412$34,500$40,335$1,118,524
Part VII, Section A: From org is column D, Other is column F.Schedule J, Part II: Base is column B(i), Bonus B(ii), Other B(iii), Deferred C, Nontaxable D, Total E.

These figures come from Howard Hughes Medical Institute's Form 990 returns, as the IRS publishes them. The methodology page explains how they're chosen. To report an error, email corrections@ceopaycheck.com.

How Howard Hughes Medical Institute compares

Ranked 4th of 11 disease charities and medical research groups by CEO pay.

Closest in revenue among organizations in the same revenue band:

Common questions